Ceva Santé Animale
Ceva Santé Animale is one of the fastest growing top 10 animal healthcare companies, currently at 5th position worldwide and 2nd in poultry, with the shared purpose to combat the world's major animal health challenges.
The company is focused on the research, development, production and marketing of pharmaceutical products and vaccines for companion animal, poultry, ruminant and swine.
Our Poultry Teams are committed to helping our customers optimise their performance and face disease challenges through innovative solutions and field support.
This committment to invest in poultry production led us to making avaiable an extensive range of solutions for prevention of major diseases such as Newcastle Disease, Gumboro Disease, Infectious Bronchitis, Avian Influenza, Coccidiosis, Larynotracheitis.
Transmune®, ULTIFEND® IBD ND, Vectormune® ND, Vectormune® FP-LT, Vectormune® AI, Cevac IBird®, Immucox 3®, C.H.I.C.K. Program®, Dovac®, Egginject®, Laserlife®, Ovosense®, are our main brands marking the innovation on both the field of biotechnology and on the services, equipment and support to ensure you get the full value from your investment in poultry health.
The company is truly global, based in 46 countries and working across more than 110. Ceva has 12 R&D centres, 25 production sites and more than 6000 employees worldwide.